Cadila Pharmaceuticals Limited

Cadila Pharmaceuticals Limited is one of India’s leading privately held pharmaceutical companies, headquartered in Ahmedabad, Gujarat. Founded in 1951 by Shri Indravadan A. Modi, the company has grown over more than seven decades into an integrated pharmaceutical enterprise focused on research, manufacturing and marketing of affordable, high-quality medicines.

The company operates across a broad range of pharmaceutical businesses, including formulations, APIs, generics, biologics, vaccines, consumer healthcare and contract manufacturing. Its research and development activities cover more than 45 therapeutic areas and 12 medical specialities, supported by a multidisciplinary team of more than 300 scientists and researchers.

Cadila Pharmaceuticals has manufacturing and research facilities across locations including Dholka, Ankleshwar, Jammu, Udaipur and Dahej, with its products and operations extending to international markets. The company places strong emphasis on innovation, quality, technology and affordable healthcare, with the objective of developing solutions that address diverse healthcare needs in India and globally.

With its extensive manufacturing capabilities, research expertise and global reach, Cadila Pharmaceuticals continues to contribute to the development of India's pharmaceutical and healthcare industry.